Adiponectin, an adipocyte derived polypeptide, has been shown to alleviate steatosis, and inflammation in mice with nonalcoholic fatty liver disease (NAFLD) (9). This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.